Duavive
oestrogens conjugated
bazedoxifene
Postmenopause
Date of authorisation:
Revision: 15
Last updated:
MedicineHumanAuthorised
Conbriza
bazedoxifene
Osteoporosis, Postmenopausal
Date of authorisation:
Revision: 15
Last updated:
MedicineHumanAuthorised
Folotyn
pralatrexate
Lymphoma, T-Cell
Date of refusal:
Last updated:
MedicineHumanRefused
EMEA-000619-PIP02-10 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Oncology
PIP number: P/270/2010
Route(s) of administration: Intravenous useIntrathecal use
Pharmaceutical form(s):
Solution for injection
Solution for infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000998-PIP01-10 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism
PIP number: P/155/2010
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Brilence
bazedoxifene
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application